Superstring Capital Management LP Cytokinetics Inc Transaction History
Superstring Capital Management LP
- $84 Billion
- Q1 2025
A detailed history of Superstring Capital Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Superstring Capital Management LP holds 72,992 shares of CYTK stock, worth $2.47 Million. This represents 3.49% of its overall portfolio holdings.
Number of Shares
72,992
Previous 129,389
43.59%
Holding current value
$2.47 Million
Previous $6.09 Billion
51.8%
% of portfolio
3.49%
Previous 5.27%
Shares
6 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$496 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$400 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$336 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$270 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$206 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.18B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...